Prograf 5 mg hard capsules, Prograf 5 mg/ml concentrate for solution for infusion, AT-1501 190 mg Vial, Prograf 0.5 mg hard capsules, Prograf 1 mg hard capsules
AT-1501-K209
Phase 2 small_molecule active
Quick answer
Prograf 5 mg hard capsules, Prograf 5 mg/ml concentrate for solution for infusion, AT-1501 190 mg Vial, Prograf 0.5 mg hard capsules, Prograf 1 mg hard capsules for Prophylaxis of Renal Allograft Rejection is a Phase 2 program (small_molecule) at Eledon Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eledon Pharmaceuticals
- Indication
- Prophylaxis of Renal Allograft Rejection
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active